Literature DB >> 8058149

Inter- and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy.

V Chaudhry1, A M Corse, M L Freimer, J D Glass, E D Mellits, R W Kuncl, S A Quaskey, D R Cornblath.   

Abstract

We determined the inter- and intraexaminer reliability of nerve conduction measurements in six patients with diabetic peripheral neuropathy. Each patient was examined by six electromyographers on two separate occasions at least 1 week apart. We obtained attributes of nerve conduction at each examination and analyzed the data by analysis of variance. Intraexaminer reliability was high for 11 of 12 measurements, and interexaminer reliability was high for eight of twelve. Three of the four measurements that varied between examiners were either sensory or motor amplitudes, attributes frequently used to measure disease progression or to assess the result of therapeutic intervention. Our results suggest that longitudinal nerve conduction measurements used to assess worsening or improvement over time should optimally be performed by a single examiner to minimize the degree of variability associated with different examiners.

Entities:  

Mesh:

Year:  1994        PMID: 8058149     DOI: 10.1212/wnl.44.8.1459

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings.

Authors:  Caraceni Augusto; Miccoli Pietro; Martini Cinzia; Curzi Sergio; Cresta Sara; Gianni Luca; Vidmer Scaioli
Journal:  J Neurooncol       Date:  2007-07-05       Impact factor: 4.130

Review 2.  Measurement of somatic neuropathy for clinical practice and clinical trials.

Authors:  L V Scott; S Tesfaye
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

3.  Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy.

Authors:  G Said; D Baudoin; K Toyooka
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

4.  Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations.

Authors:  Kathleen A Griffith; Darren J Couture; Shijun Zhu; Naimish Pandya; Mary E Johantgen; Guido Cavaletti; Joan M Davenport; Lori J Tanguay; Amanda Choflet; Todd Milliron; Erica Glass; Nancy Gambill; Cynthia L Renn; Susan G Dorsey
Journal:  Support Care Cancer       Date:  2013-12-21       Impact factor: 3.603

5.  Screening for critical illness polyneuromyopathy with single nerve conduction studies.

Authors:  Marc Moss; Michele Yang; Madison Macht; Peter Sottile; Laura Gray; Monica McNulty; Dianna Quan
Journal:  Intensive Care Med       Date:  2014-03-13       Impact factor: 17.440

6.  Relationship of Vascular Factors on Electrophysiologic Severity of Diabetic Neuropathy.

Authors:  Jeong-Won Hwang; Sung-Bom Pyun; Hee Kyu Kwon
Journal:  Ann Rehabil Med       Date:  2016-02-26

7.  Inter-practitioner comparisons of nerve conduction studies with standardized techniques in normal subjects: Reap as you sow.

Authors:  Bing Zhao; Hong-Mei Diao; Qing-Xian Wen; Ke-Xv Sui; Yong-Qing Zhang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.